Imedex E-learning (audio)

Novel DOAC Reversal Strategies: Update on Best Practices - Mark A. Munger, PharmD, FCCP, FACC, FHFSA, Randolph V. Fugit, PharmD, BCPS, and Paul P. Dobesh, PharmD, FCCP, BCPS, BCCP

Informações:

Sinopsis

Learn about the mechanisms of action and safety/efficacy data for currently-approved DOAC reversal agents, and gain insight into comprehensive care strategies that facilitate multidisciplinary management of patients at risk for DOAC-related bleeding.